Loading Events

« All Events

  • This event has passed.

Anavex Life Sciences to Present at the 13th International Conference on Alzheimer’s and Parkinson’s Diseases AD/PD™ 2017

March 30, 2017 - April 1, 2017

Christopher U. Missling, PhD, President and Chief Executive Officer, will be presenting twice and participating on a panel discussion at the following times.

Panel Title: AD/PD™ 2017 FORUM ON TRANSLATIONAL RESEARCH IN DRUG DISCOVERY FOR AD: A PLETHORA OF TARGETS: WHICH IS THE BEST, IS THERE “A BEST ONE”?
Date/Time: Thursday, March 30; 2:45 p.m. – 4:45 p.m. CET
Location: HALL A

Oral Presentation Title: TARGETING M1 MUSCARINIC AND SIGMA-1 RECEPTORS IN ALZHEIMER’S DISEASE: REVERSAL OF PATHOLOGICAL HALLMARKS AND ASSOCIATED COGNITIVE DYSFUNCTION IN MCGILL-R-THY1-APP RATS (Data related to ANAVEX 3-71)
Date/Time: Thursday, March 30; 7.00 p.m. – 7.15 p.m. CET
Location: HALL A

Poster Presentation Title: THE DUAL REGULATION OF OXIDATIVE STRESS BY SIGMA1 RECEPTORS IN PHYSIOLOGICAL OR PATHOLOGICAL CONDITIONS (Data related to ANAVEX 2-73, ANAVEX 3-71, ANAVEX 1-41)
Date/Time: Saturday, April 1; 8.00 a.m. – 6.00 p.m. CET
Location: Poster Number 007

Details

Start:
March 30, 2017
End:
April 1, 2017
Event Category:
Website:
http://adpd2017.kenes.com/

Venue

Austria Centre
Bruno-Kreisky-Platz 1
Wien, Austria
Phone:
+43 1 260690
Website:
https://www.acv.at/index.en.html